Efficacy of repeated adenoviral suicide gene therapy in a localized murine tumor model

This publication has 21 references indexed in Scilit:

• Impact of Preexisting and Induced Humoral and Cellular Immune Responses in an Adenovirus-Based Gene Therapy Phase I Clinical Trial for Localized Mesothelioma
  Human Gene Therapy, 1998
• Adenovirus-Mediated Herpes Simplex Virus Thymidine Kinase/Ganciclovir Gene Therapy in Patients with Localized Malignancy: Results of a Phase I Clinical Trial in Malignant Mesothelioma
  Human Gene Therapy, 1998
• Human Gene Marker/Therapy Clinical Protocols (Complete Updated Listings)
  Human Gene Therapy, 1997
• A “Distant” Bystander Effect of Suicide Gene Therapy: Regression of Nontransduced Tumors Together with a Distant Transduced Tumor
  Human Gene Therapy, 1997
• Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression
  Gene Therapy, 1997
• Safety of Intrapleurally Administered Recombinant Adenovirus Carrying Herpes Simplex Thymidine Kinase DNA Followed by Ganciclovir Therapy in Nonhuman Primates
  Human Gene Therapy, 1996
• The Role of Immunosuppression in the Efficacy of Cancer Gene Therapy Using Adenovirus Transfer of the Herpes Simplex Thymidine Kinase Gene
  Annals of Surgery, 1995
• Treatment of Experimental Human Mesothelioma Using Adenovirus Transfer of the Herpes Simplex Thymidine Kinase Gene
  Annals of Surgery, 1995
• Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors.
  Proceedings of the National Academy of Sciences, 1994
• Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1–deleted adenoviruses
  Nature Genetics, 1993